Skip to Content

Pranlukast

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R03DC02

CAS registry number (Chemical Abstracts Service)

0103177-37-3

Chemical Formula

C27-H23-N5-O4

Molecular Weight

482

Therapeutic Categories

Antiasthmatic agent

Anti-inflammatory agent

Leukotrien receptor antagonist

Chemical Names

N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-p-(4-phenylbutoxy)benzamide

N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-p-(4-phenylbutoxy)benzamide (WHO)

Foreign Names

  • Pranlukastum (Latin)
  • Pranlukast (German)
  • Pranlukast (French)
  • Pranlukast (Spanish)

Generic Names

Brand Names

  • Azlaire
    Merck Sharp & Dohme, Mexico; Schering-Plough, Ecuador
  • Prakanon
    Yuhan, South Korea
  • Pranlukast - Hengrui Medicine
    HengRui Medicine, China
  • Pranlux
    Neutec Inhaler, Turkey
  • Azlaire
    Merck Sharp & Dohme, Mexico; Schering-Plough, Venezuela
  • Citus
    Sama Pharmaceuticals, South Korea
  • Ofran
    Sungwon Adcock, South Korea
  • Onon
    Dong-A, South Korea; Ono Yakuhin, Japan
  • Onon 10%
    Ono Yakuhin, Japan
  • Pranair
    SK Chemical Life Science, South Korea
  • Pranlukast
    Alfresa Pharma, Japan; Ceolia Pharma, Japan; Daiko Seiyaku, Japan; Kobayashi Kako, Japan; Mylan Seiyaku, Japan; Nichi-Iko Pharmaceutical, Japan; Sawai Seiyaku, Japan; Shiono Kemikaru, Japan; Takeda Teva Pharma, Japan; Towa Yakuhin, Japan; Yakuhan Seiyaku, Japan
  • Pranlukast 10%
    Alfresa Pharma, Japan; Daiko Seiyaku, Japan; Mylan Seiyaku, Japan; Nihon Generic, Japan; Nipro, Japan; Takeda Teva Pharma, Japan
  • Pranlukast DS 10%
    Kobayashi Kako, Japan; Kyowa Yakuhin, Japan; Nichi-Iko Pharmaceutical, Japan; Ohara Yakuhin, Japan; Sawai Seiyaku, Japan; Takata Pharmaceutical, Japan; Takeda Teva Pharma, Japan; Tatsumi Kagaku, Japan; Towa Yakuhin, Japan

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide